进行性转移性恶性肿瘤的临床试验
总计12150个结果
-
Korea University Guro HospitalKorean Cancer Study Group主动,不招人
-
Samsung Medical Center主动,不招人
-
National Cancer Institute (NCI)终止
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.招聘中
-
Jiangsu HengRui Medicine Co., Ltd.招聘中
-
Canadian Cancer Trials GroupAstraZeneca主动,不招人
-
Innovent Biologics (Suzhou) Co. Ltd.完全的
-
Bristol-Myers SquibbOno Pharmaceutical Co. Ltd完全的
-
Southwest Hospital, China未知
-
University of KentuckyArno Therapeutics完全的
-
Novartis Pharmaceuticals终止
-
Sigma-Tau Research, Inc.Dana-Farber Cancer Institute; Rhode Island Hospital完全的
-
Heidelberg Pharma AGUnited States Department of Defense完全的
-
Medical College of Wisconsin完全的Malignancies, Hematologic美国
-
Mayo ClinicNational Institute on Deafness and Other Communication Disorders (NIDCD)招聘中
-
Parker Institute for Cancer ImmunotherapyBristol-Myers Squibb; Cancer Research Institute, New York City完全的
-
Ohio State University Comprehensive Cancer Center招聘中
-
Biogen完全的多发性硬化症 | 复发缓解型多发性硬化症 | 继发性进行性多发性硬化症 | 多发性硬化症,原发进展 | 多发性硬化症,间歇性进展日本
-
Daiichi SankyoAstraZeneca招聘中
-
Memorial Sloan Kettering Cancer CenterRepare Therapeutics招聘中
-
Imperial College LondonCuresponse Ltd.尚未招聘
-
Meryx, Inc.主动,不招人
-
Samsung Medical Center完全的
-
P.O. WitteveenErasmus Medical Center; The Netherlands Cancer Institute终止
-
Virginia Commonwealth University终止
-
Institut Cancerologie de l'Ouest完全的
-
Assistance Publique Hopitaux De Marseille完全的
-
Weill Medical College of Cornell UniversityGenzyme, a Sanofi Company完全的
-
The Hong Kong Polytechnic UniversityAston University; Queensland University of Technology; Menicon Co., Ltd.完全的
-
IRCCS San Raffaele招聘中